Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

UK launch of generic lenalidomide for myeloma

January 19, 2022 Research and Development

Accord Healthcare have announced the UK launch of generic lenalidomide, available for the treatment of adult patients with multiple myeloma, …
News

SMC accepts first-line treatment for lung cancer

January 19, 2022 Research and Development

The SMC has accepted AstraZeneca’s Tagrisso (osimertinib) for use as monotherapy for the first-line treatment of adult patients with locally …
News

White House announces plans to double COVID-19 tests for schools

January 12, 2022 Research and Development

The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …
News

South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine

January 12, 2022 Research and Development

Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …
News

WHO experts warn against repeated boosters as strategy against COVID-19

January 12, 2022 Research and Development

Repeating booster doses of the original COVID-19 vaccines is not a viable strategy against emerging variants, WHO has shared, predicting …
News

MHRA Approves Vertex’s Kaftrio combination with ivacaftor for Children With cystic fibrosis

January 12, 2022 Research and Development

Vertex Pharmaceuticals have announced the MHRA approval of the label extension of Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor, …
News

Bharat Biotech receives approval to test nasal COVID-19 shot as booster

January 5, 2022 Research and Development

India’s drug regulator has granted approval to Bharat Biotech, for late stage trials of its nasal COVID-19 vaccine to be …
News

FDA grants breakthrough therapy designation to novel EGFR inhibitor

January 5, 2022 Research and Development

The FDA has granted a  breakthrough therapy designation to Cullian Oncology’s CLN-081, in certain patients with locally advanced or metastatic …
News

NaNotics and Mayo Clinic to collaborate on nanomedicine cancer treatment

January 5, 2022 Research and Development

Nanomedical company NaNotics have announced a research collaboration with Mayo Clinic, to develop a NaNot that targets the soluble form …
News
fahczjixoai9a8z

NICE recommends PONVORY for the treatment of relapsing forms of multiple sclerosis

January 5, 2022 Research and Development

NICE has issued a positive Final Appraisal Document (FAD) recommending PONVORY® (ponesimod) as an option in England and Wales for …
News

Avacta lateral flow test receives CE mark for consumer self-testing

December 22, 2021 Research and Development

Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® …
News

South African study suggests Omicron has a lower risk of hospitalisation than Delta

December 22, 2021 Research and Development

A new South African study suggests that there are reduced risks of hospitalisation and severe disease in people infected with …
News

FDA places clinical hold on use of injectable lenacapavir for HIV treatment

December 22, 2021 Research and Development

The FDA has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials, in all ongoing clinical …
News
fgfwekgwyam8rvv

EMA recommends Nuvaxovid for authorisation, as WHO grants second Emergency Use Listing

December 22, 2021 Research and Development

Nuvaxovid™, the COVID-19 vaccine manufactured by the biotechnology company Novavax, has been listed for emergency use by WHO. The news …
News

Pfizer shares efficacy of COVID pill: near 90% protection against hospitalisation

December 15, 2021 Research and Development

Pfizer have announced that a final analysis of the antiviral pill Paxlovid (nirmatrelvir tablets and ritonavir tablets) shows 89% reduction …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026